Increasing Demand For Biopharmaceuticals Fueling The Growth Of The Market Amid Rising Chronic And Complex Disease Burden Is Supporting Development Across The Spray-Dried Biologics Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Spray-Dried Biologics Market Increase Between 2026 And 2030?

The spray-dried biologics market has expanded substantially in recent years. It is anticipated to grow from $1.86 billion in 2025 to $2.08 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.7%. This historical growth can be attributed to several factors such as advancements in biologics formulation science, a rise in biologic drug approvals, the necessity for improved drug stability, the expansion of vaccine manufacturing capacity, and the adoption of advanced pharmaceutical processing technologies.

The spray-dried biologics market is projected to undergo rapid expansion in the coming years. It is forecast to grow to $3.2 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 11.4%. This growth over the forecast period is driven by increasing demand for non-injectable biologics, rising investments in dry powder delivery systems, the expansion of global vaccine production, a growing focus on cold-chain reduction, and advancements in spray-drying equipment design. Key trends anticipated during this period include increasing adoption of spray-drying for biologic stability, rising demand for inhalable and oral biologic formulations, the expansion of continuous spray-drying processes, the growing use of dry powder biologics in vaccines, and an enhanced focus on shelf-life extension.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30401&type=smp

What Major Growth Factors Are Impacting The Spray-Dried Biologics Market?

The escalating need for biopharmaceuticals is projected to significantly advance the spray-dried biologics market in the coming years. These are medicinal products originating from biological entities such as living cells, proteins, and other biomolecules. The rise in biopharmaceutical demand stems from a worldwide increase in chronic and intricate health conditions, necessitating treatments with enhanced specificity, better efficacy, and reduced systemic side effects. Consequently, the spray-dried biologics industry sees increased demand because the swift growth of biopharmaceuticals encourages companies to implement scalable formulation methods that enhance product stability, extend shelf life, and boost delivery efficiency. As an illustration, in February 2025, the World Health Organization (WHO), an international public health body headquartered in Switzerland, reported that its 2023 essential medicines list (EML) featured 81 biologic therapies, constituting over 15% of all essential medicines. Thus, the escalating requirement for biopharmaceuticals is a primary impetus for the expansion of the spray-dried biologics market.

What Are The Major Segment Categories Within The Spray-Dried Biologics Market?

The spray-dried biologics market covered in this report is segmented –

1) By Product Type: Monoclonal Antibodies, Vaccines, Enzymes, Hormones, Other Product Types

2) By Route Of Administration: Oral, Inhalation Or Pulmonary, Injectable, Topical

3) By End-User: Hospitals, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Monoclonal Antibodies: Chimeric Antibodies, Humanized Antibodies, Fully Human Antibodies, Bispecific Antibodies, Antibody Fragments

2) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Viral Vector Vaccines, Recombinant Protein Vaccines

3) By Enzymes: Therapeutic Enzymes, Digestive Enzymes, Metabolic Enzymes, Recombinant Enzymes, Replacement Enzymes

4) By Hormones: Peptide Hormones, Protein Hormones, Steroid Hormones, Recombinant Hormones, Growth Hormones

5) By Other Product Types: Blood Factors, Cytokines, Fusion Proteins, Nucleic Acid Therapeutics, Cell Culture Media Proteins

What Trends Are Impacting The Spray-Dried Biologics Market?

Leading companies in the spray-dried biologics market are concentrating on integrating technological advancements, such as drum dosing technology, to improve dose accuracy, powder handling efficiency, and reliable large-scale capsule filling. Drum dosing technology is an advanced method for filling powders that employs a rotating drum with precisely engineered dosing cavities and vacuum-assisted transfer to accurately meter and deposit dry powders into capsules. This enables features like consistent low-dose filling, enhanced flow management of spray-dried powders, and high-throughput scalability. For example, in February 2024, Catalent Inc., a US-based contract development and manufacturing organization (CDMO), enhanced its US inhalation manufacturing facility by incorporating potent capsule-filling capabilities powered by drum-based dosing systems and in-line advanced mass verification. This upgraded platform facilitates the accurate filling of engineered and spray-dried powders, featuring real-time dose validation and controlled low-humidity processing. This improvement boosts manufacturing efficiency, product consistency, and the readiness for commercial-scale production of spray-dried biologic dry-powder inhalation therapies.

Who Are The Prominent Players Across The Spray-Dried Biologics Market?

Major companies operating in the spray-dried biologics market are Thermo Fisher Scientific Inc., Evonik Industries AG, Lonza Group AG, GEA Group, Fareva Group, Almac Group Limited, Seqens Group, Fabbrica Italiana Sintetici S.p.A., CordenPharma International, Hovione FarmaCiencia SA, Veranova Inc., Pace Analytical Services LLC, Olon S.p.A., Nova Laboratories Ltd, Leukocare AG, Micro Sphere SA, Seran Bioscience LLC, CritiTech Particle Engineering Solutions LLC, Xedev BV, BÜCHI Labortechnik AG.

Access The Complete Spray-Dried Biologics Market Report:

https://www.thebusinessresearchcompany.com/report/global-spray-dried-biologics-market-report

Which Area Represents The Largest Portion Of The Spray-Dried Biologics Market?

North America was the largest region in the spray-dried biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spray-dried biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Spray-Dried Biologics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=30401&type=smp

Browse Through More Reports Similar to the Global Spray-Dried Biologics Market 2026, By The Business Research Company

Biologics Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Spray Drying Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/spray-drying-equipment-global-market-report

Agricultural Biologics Market Report 2026

https://www.thebusinessresearchcompany.com/report/agricultural-biologics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795